Inventor
HUNG GENE
US34 patents
⚠️ This page may combine multiple inventors who share the name “HUNG GENE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IONIS PHARMACEUTICALS INC
15 patentsUS10006027B2Jun 26, 2018
Methods for modulating Ataxin 2 expression
IONIS PHARMACEUTICALS INC21 citations93
US9683236B2Jun 20, 2017
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC5 citations84
US11136577B2Oct 5, 2021
Methods and compositions for inhibiting PMP22 expression
IONIS PHARMACEUTICALS INC4 citations83
US10533178B2Jan 14, 2020
Methods for modulating Ataxin 2 expression
IONIS PHARMACEUTICALS INC6 citations83
US11834660B2Dec 5, 2023
Compositions for modulating Ataxin 2 expression
IONIS PHARMACEUTICALS INC2 citations73
US11421231B2Aug 23, 2022
Modulation of Huntington expression
IONIS PHARMACEUTICALS INC1 citations73
US10837016B2Nov 17, 2020
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC2 citations73
US10738307B2Aug 11, 2020
Compositions and their uses directed to huntingtin
IONIS PHARMACEUTICALS INC1 citations73
US10619158B2Apr 14, 2020
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC2 citations73
US10202603B2Feb 12, 2019
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC2 citations73
US9523094B2Dec 20, 2016
Methods of treating kennedy's disease
IONIS PHARMACEUTICALS INC3 citations73
US11959080B2Apr 16, 2024
Methods and compositions for inhibiting PMP22 expression
IONIS PHARMACEUTICALS INC1 citations72
US12509681B2Dec 30, 2025
Antisense oligonucleotides directed to huntingtin
IONIS PHARMACEUTICALS INC0 citations62
US12529055B2Jan 20, 2026
Methods and compositions for inhibiting PMP22 expression
IONIS PHARMACEUTICALS INC0 citations61
US12297431B2May 13, 2025
Modulation of huntingtin expression
IONIS PHARMACEUTICALS INC0 citations60
ALUMIS INC
4 patentsUS12006306B2Jun 11, 2024
Substituted pyridazines as TYK2 inhibitors
ALUMIS INC1 citations71
US11731956B2Aug 22, 2023
Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors
ALUMIS INC1 citations71
US12351572B2Jul 8, 2025
Substituted 1,2,4-triazoles as TYK2 inhibitors
ALUMIS INC0 citations61
US12060343B2Aug 13, 2024
Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors
ALUMIS INC0 citations61
FRONTHERA U S PHARMACEUTICALS LLC
3 patentsUS11053219B2Jul 6, 2021
Substituted pyridines as TYK2 inhibitors
FRONTHERA U S PHARMACEUTICALS LLC9 citations83
US10711000B2Jul 14, 2020
Autotaxin inhibitors and uses thereof
FRONTHERA U S PHARMACEUTICALS LLC1 citations60
US10787430B2Sep 29, 2020
Hemoglobin modifier compounds and uses thereof
FRONTHERA U S PHARMACEUTICALS LLC0 citations39